Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01949623 · ClinicalTrials.gov registry record
Biomarkers In Retinitis Pigmentosa (BIRP)
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 100
- Enrollment target
NCT01949623: Completed study, sponsored by Johns Hopkins University.
NCT01949623 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01949623 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
In this study, markers of oxidative stress will be measured in the aqueous humour and plasma of RP patients compared to controls.
Interventions
- OTHER Anterior Chamber (AC) tap
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-09 |
| Est. Completion | 2017-07 |
What the finished NCT01949623 record still lists
NCT01949623 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Anterior Chamber (AC) tap is the first listed.
NCT01949623 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01949623 about?
NCT01949623 is a clinical study titled "Biomarkers In Retinitis Pigmentosa (BIRP)". In this study, markers of oxidative stress will be measured in the aqueous humour and plasma of RP patients compared to controls.
What is the current status of trial NCT01949623?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2013-09. Estimated completion is 2017-07.
What interventions are being tested in trial NCT01949623?
The interventions under investigation include: Anterior Chamber (AC) tap (OTHER).
Who is sponsoring clinical trial NCT01949623?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia